A detailed history of Castleark Management LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Castleark Management LLC holds 49,170 shares of TMDX stock, worth $2.99 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
49,170
Previous 42,900 14.62%
Holding current value
$2.99 Million
Previous $6.46 Million 19.47%
% of portfolio
0.32%
Previous 0.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$135.68 - $176.11 $850,713 - $1.1 Million
6,270 Added 14.62%
49,170 $7.72 Million
Q2 2024

Aug 13, 2024

BUY
$72.62 - $150.62 $3.12 Million - $6.46 Million
42,900 New
42,900 $6.46 Million
Q2 2023

Aug 15, 2023

BUY
$66.23 - $88.73 $83,449 - $111,799
1,260 Added 0.96%
132,535 $11.1 Million
Q4 2022

Feb 09, 2023

BUY
$39.08 - $64.29 $509,212 - $837,698
13,030 Added 11.02%
131,275 $8.1 Million
Q3 2022

Nov 15, 2022

BUY
$31.56 - $55.75 $3.73 Million - $6.59 Million
118,245 New
118,245 $4.94 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.94B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.